More articles from Editorial

You have access
Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes
Zhao Bi, Pengfei Qiu, Zhaopeng Zhang and Yongsheng Wang

Cancer Biology & Medicine December 2022, 19 (12) 1617-1621; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0590
You have access
Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers
Michael Baumann

Cancer Biology & Medicine November 2022, 19 (11) 1517-1522; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0586
You have access
Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment
Weiling Chen, Guimei Wang and Guojun Zhang

Cancer Biology & Medicine October 2022, 19 (10) 1487-1495; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0440
You have access
Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies
Lingxiang Wu, Ruichao Chai, Zheng Zhao, Qianghu Wang and Tao Jiang

Cancer Biology & Medicine October 2022, 19 (10) 1423-1427; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0363
You have access
Reflections on the withdrawal of medical articles and the development of writing and publishing standards
Lidong Wang and Zhihua Liu

Cancer Biology & Medicine September 2022, 19 (9) 1283-1289; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0437
You have access
Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang

Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403
You have access
Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF
Hongquan Wang, Shuang Wu, Yan Wang and Bo Tang

Cancer Biology & Medicine July 2022, 19 (7) 945-947; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0299
You have access
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
Jianbin Li and Zefei Jiang

Cancer Biology & Medicine June 2022, 19 (6) 769-773; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0277
You have access
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
Han Liang

Cancer Biology & Medicine May 2022, 19 (5) 565-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0244
You have access
A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
Yuchen Guo, Yangyang Zhou and Wenxin Qin

Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520

Main menu

User menu

Search

More articles from Editorial

Pages

Navigate

More Information

For Authors

Journal Services